AU:MXC's free cash flow for Q4 2022 was AU$―. For the 2022 fiscal year, AU:MXC's free cash flow was decreased by AU$1.89M and operating cash flow was AU$―. See a summary of the company’s cash flow.

Cash Flow	TTM	Jun 23	Jun 22	Jun 21	Jun 20	Jun 19
Operating Cash Flow	-	AU$ -11.99M	AU$ -12.16M	-	-	-
Investing Cash Flow	-	AU$ 606.20K	AU$ -1.11M	AU$ -1.49M	AU$ -969.88K	AU$ -947.03K
Financing Cash Flow	-	AU$ 9.73M	AU$ 9.74M	AU$ 17.05M	AU$ 10.46M	AU$ 27.01K
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	-	AU$ 249.28K	AU$ 1.89M	AU$ 5.43M	AU$ 1.87M	AU$ 2.35M
Income Tax Paid Supplemental Data	-	-	-	-	-	AU$ 27.32K
Interest Paid Supplemental Data	-	-	-	AU$ 7.40K	AU$ 135.58K	AU$ 444.00
Issuance Of Capital Stock	-	AU$ 3.09M	AU$ 10.70M	AU$ 12.76M	AU$ 11.43M	AU$ 35.96K
Issuance Of Debt	-	AU$ 6.96M	AU$ -201.58K	AU$ 5.75M	-	-
Repayment Of Debt	-	AU$ -200.96K	AU$ -263.01K	-	-	-
Free Cash Flow	-	AU$ -11.38M	AU$ -13.26M	-	AU$ -10.92M	AU$ -6.72M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in AUD

MGC Pharmaceuticals Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing